VIAVI SOLUTIONS INC. reported its fiscal third quarter ended March 28, 2026 results: revenue Net revenue of $406.8 million, net income GAAP net income of $6.4 million, EPS GAAP diluted earnings per share (EPS) of $0.03.
“April 29, 2026 — VIAVI (NASDAQ: VIAV) today reported results for its fiscal third quarter ended March 28, 2026 with the following highlights. Third Quarter • Net revenue of $406.8 million, up $122.0 million or 42.8% year-over-year • GAAP operating margin of 6.1%, up 310 bps year-over-year • Non-GAAP operating margin of 21.0%, up 430 bps year-over-year • GAAP net”
Restructurings & Charges
VIAVI SOLUTIONS INC. announced a restructuring with charges of approximately $32 million (approximately 5% of its global workforce).
“and asset write-offs. The Company expects approximately 5% of its global workforce to be affected. The Company estimates it will incur total charges of approximately $32 million in connection with the Plan, including approximately $24 million in cash expenditures, primarily related to employee severance and related costs. The Company expects to recognize”
Governance Changes
VIAVI SOLUTIONS INC.: Filed amended and restated certificate of incorporation to add an officer exculpation provision approved by stockholders at the annual meeting (effective 2025-11-13).
“On November 12, 2025, Viavi Solutions Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved amendments to the Company’s existing Fourth Restated Certificate of Incorporation as disclosed in Item 5.07 below. The amendments provide for officer exculpation as permitted by the Delaware General Corporation Law, as further described in the Company's definitive proxy statement filed on October 3, 2025, under the heading “Proposal 5 - Approval of an Amended and Restated Certificate of Incorporation to Include an Officer Exculpation Provision.” Subsequent to the approval, the Company filed on November 13, 2025, with the Secretary of the State of Delaware, an Amended and Restated Certificate of Incorporation, which became effective upon filing.”
Debt Financings
VIAVI SOLUTIONS INC. amended revolving credit of $200 million with Wells Fargo maturing the earlier of October 16, 2030 and a springing maturity date 91 days prior to the maturity of certain existing notes issued by the Company.
“The Amendment decreases the size of the revolving credit facility from an aggregate principal amount of $300 million to $200 million, and extends the maturity date of the Amended ABL Credit Agreement to the earlier of October 16, 2030 and a springing maturity date 91 days prior to the maturity of certain existing notes issued by the Company.”
Debt Financings
VIAVI SOLUTIONS INC. incurred term loan of $600 million with Wells Fargo Bank, National Association at Term SOFR plus a margin of (a) 2.50% if the Company’s first lien leverage ratio maturing October 16, 2032.
“The Term Loan Credit Agreement provides for a senior secured term loan facility in an aggregate principal amount of $600 million (the “Term Loans”), which was borrowed in full at closing and which matures on October 16, 2032.”
Debt Financings
VIAVI SOLUTIONS INC. incurred convertible notes of $250 million aggregate principal amount with institutional accredited investors and qualified institutional buyers at 0.625% per annum maturing March 1, 2031.
“On August 20, 2025, in connection with the consummation of previously announced private transactions, Viavi Solutions Inc. (the “Company”) issued $250 million aggregate principal amount of its 0.625% Senior Convertible Notes due 2031 (the “New Notes”) under an Indenture, dated August 20, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.